MD PhD Institut Pasteur de Montevideo Montevideo, Montevideo, Uruguay
Disclosure(s):
Marcelo Hill, MD, PhD: ARDAN Pharma: Equity/Owner (Ongoing), Grant Support (Ongoing), Patents/Royalty (Ongoing); Institut Roche: Grant Support (Ongoing)
Learning Objectives:
Upon completion, participants will be able to understad the immunological links between inflammasome activation and T cell exhaustion.
Under completion, participants will know pharmacological approaches to trigger inflammasome activation.
Upon completion, participants will know the role of immunoregulatory cation channels such as TMEM176B.
